BBIO
BBIO
US10806X1028
BridgeBio Pharma, Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 502.076.000 221.902.000
126.3%
Cost of Revenue 20.962.000 3.878.000
440.5%
Gross Profit 481.114.000 218.024.000
120.7%
983.178.000 795.392.000
23.6%
Operating Income -502.064.000 -577.368.000
13.0%
Pretax Income -732.503.000 -542.194.000
35.1%
Net Income Common Stockholders -724.931.000 -535.762.000
35.3%
-- --
--
-- --
--
ende